GE, iBio unite on plant-based production of vaccines and biologics

GE Healthcare and iBio ($IBIO) will partner to commercialize plant-based technologies for manufacturing biopharmaceuticals and vaccines. The pair already have a development and marketing agreement, which was announced in 2010. The new alliance combines iBio's plant-based vaccine manufacturing platform, iBioLaunch, with GE Healthcare's start-to-finish biopharmaceutical manufacturing technologies. Release